Partilhar
Informação da revista
Os mais lidos
12735
Cronotropismo no esforço. Inconsistências metodológicas e conceptuaisMiguel Mendes
Rev Port Cardiol. 2021;40:955-6
12735
Open access
9506
Pace and ablate: The ultimate treatment for atrial fibrillation?Pedro Carmo
Rev Port Cardiol. 2021;40:105-7
9506
Open access
8960
Optimization of heart failure with reduced ejection fraction prognosis-modifying drugs: A 2021 heart failure expert consensus paperJosé Silva-Cardoso, Cândida Fonseca, Fátima Franco, João Morais, Jorge Ferreira, Dulce Brito
Rev Port Cardiol. 2021;40:975-83
8960
Open access
8735
Cardiac arrhythmias in patients presenting with COVID-19 treated in Portuguese hospitals: A national registry from the Portuguese Association of Arrhythmology, Pacing and ElectrophysiologyDinis Mesquita, Pedro Carmo, Nuno Cabanelas, Nuno Santos, Vítor Martins, Victor Sanfins, Helena Cristina Costa, José Paulo Fontes, ... on behalf of the Portuguese Association of Arrhythmology, Pacing and Electrophysiology (APAPE)
Rev Port Cardiol. 2021;40:573-80
8735
Open access
Artigo aberto
8444
Documento de Consenso sobre a realização de ressonância magnética em doentes com dispositivos cardíacos electrónicos implantadosAna G. Almeida, Natália António, Carla Saraiva, António Miguel Ferreira, António Hipólito Reis, Hugo Marques, Nuno Dias Ferreira, Mário Oliveira
Rev Port Cardiol. 2021;40:41-52
8444
Open access
8344
Uma causa reversível de disfunção ventricular esquerda: caso clínico e breve revisãoDavid Roque, Daniel Faria, João Ferreira, Hilaryano Ferreira, Marco Beringuilho, Pedro Magno, Carlos Morais
Rev Port Cardiol. 2021;40:383-8
8344
Open access
7007
Tratamento não farmacológico da angina refratária. Dispositivo de redução do seio coronário, uma nova alternativa terapêuticaSérgio Madeira, Catarina Brízido, Luís Raposo, João Brito, Nélson Vale, Sílvio Leal, Pedro de Araújo Gonçalves, Henrique Mesquita Gabriel, ... Manuel Almeida
Rev Port Cardiol. 2021;40:371-82
7007
Open access
6782
Surviving cardiac arrest: What happens after admission to the intensive care unit?Raquel Menezes Fernandes, Daniel Nuñez, Nuno Marques, Cláudia Camila Dias, Cristina Granja
Rev Port Cardiol. 2021;40:317-25
6782
Open access
6749
Os custos da aterosclerose em PortugalJoão Costa, Joana Alarcão, Alexandre Amaral‐Silva, Francisco Araújo, Raquel Ascenção, Daniel Caldeira, Marta Ferreira Cardoso, Manuel Correia, ... Margarida Borges
Rev Port Cardiol. 2021;40:409-19
6749
Open access
6606
Effect of vitamin D supplements on left ventricular ejection fraction in patients with heart failure: A systematic review and meta-analysis of randomized controlled trialsAryan Naghedi, Hasan Haghaninejad, Hamidreza Varastehravan, Arvin Naghedi, Nima Farshadi
Rev Port Cardiol. 2021;40:447-55
6606
Open access
6591
Current status of the treatment of degenerative mitral valve regurgitationGonçalo F. Coutinho, Manuel J. Antunes
Rev Port Cardiol. 2021;40:293-304
6591
Open access
6180
The third generation of drug-eluting stents: Reassuring data while we wait for the next oneSergio Bravo Baptista
Rev Port Cardiol. 2021;40:77-80
6180
Open access
5993
Aplicabilidade da fórmula Martin‐Hopkins e comparação com a fórmula Friedewald na estimativa do colesterol LDL na população do estudo e_CORCátia Ferrinho, Ana Catarina Alves, Mafalda Bourbon, Sequeira Duarte
Rev Port Cardiol. 2021;40:715-24
5993
Open access
5879
Impact of SARS-CoV-2 pandemic on ST-elevation myocardial infarction admissions and outcomes in a Portuguese primary percutaneous coronary intervention center: Preliminary DataAndré Azul Freitas, Rui Baptista, Valdirene Gonçalves, Cátia Ferreira, James Milner, Carolina Lourenço, Susana Costa, Fátima Franco, ... Lino Gonçalves
Rev Port Cardiol. 2021;40:465-71
5879
Open access
Artigo aberto
4710
Optimizing prognosis in atrial fibrillation: A call to action in PortugalJorge Ferreira, Natália António, Nuno Cortez-Dias, Luciana Ricca Gonçalves, João Sargento-Freitas, Pedro von Hafe, Victor Gil
Rev Port Cardiol. 2021;40:595-605
4710
Open access
4568
Caffeine slows heart rate autonomic recovery following strength exercise in healthy subjectsCicero Jonas R. Benjamim, Larissa Raylane L. Monteiro, Yasmim M. de Moraes Pontes, Amanda A. Marcelino da Silva, Thays K. Marinho de Souza, Vitor E. Valenti, David M. Garner, Taisy C. Ferro Cavalcante
Rev Port Cardiol. 2021;40:399-406
4568
Open access
4541
Segurança e eficácia da angioplastia pulmonar por balão em Portugal num centro de referência em hipertensão pulmonarRita Calé, Filipa Ferreira, Ana Rita Pereira, Débora Repolho, Daniel Sebaiti, Sofia Alegria, Sílvia Vitorino, Pedro Santos, ... Maria José Loureiro
Rev Port Cardiol. 2021;40:727-38
4541
Open access
4461
Current state of cardiac rehabilitation in Portugal: Results of the 2019 national surveyJosé Paulo Fontes, Eduardo M. Vilela, Anaí Durazzo, Madalena Teixeira
Rev Port Cardiol. 2021;40:877-87
4461
Open access
4379
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in PortugalNuno Marques, Laetitia Gerlier, Mafalda Ramos, Helder Pereira, Sérgia Rocha, Ana Catarina Fonseca, Ana André, Ricardo Melo, Eduard Sidelnikov
Rev Port Cardiol. 2021;40:109-15
4379
Open access
4313
Effectiveness of preoperative breathing exercise interventions in patients undergoing cardiac surgery: A systematic reviewSoraia Nicola Rodrigues, Helga Rafael Henriques, Maria Adriana Henriques
Rev Port Cardiol. 2021;40:229-44
4313
Open access
Conteúdo especial sobre COVID-19
- Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one
- RAAS inhibitors in COVID-19: not all are created equal. Telmisartan is the one
- High prevalence of cardiovascular disease and risk factors among type 2 diabetes patients followed in a hospital setting in Portugal
- RAAS inhibitors in COVID-19: They are not all the same!
Publicar em
Revista Portuguesa de Cardiologia
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.